Literature DB >> 29161622

On Denny-Brown's 'spastic dystonia' - What is it and what causes it?

Jakob Lorentzen1, Maud Pradines2, Jean-Michel Gracies2, Jens Bo Nielsen3.   

Abstract

In this review, we will work around two simple definitions of two different entities, which most often co-exist in patients with lesions to central motor pathways: Spasticity is "Enhanced excitability of velocity-dependent responses to phasic stretch at rest", which will not be the subject of this review, while Spastic dystonia is tonic, chronic, involuntary muscle contraction in the absence of any stretch or any voluntary command (Gracies, 2005). Spastic dystonia is a much less well understood entity that will be the subject this review. Denny-Brown (1966) observed involuntary sustained muscle activity in monkeys with lesions restricted to the motor cortices . He further observed that such involuntary muscle activity persisted following abolition of sensory input to the spinal cord and concluded that a central mechanism rather than exaggerated stretch reflex activity had to be involved. He coined the term spastic dystonia to describe this involuntary tonic activity in the context of otherwise exaggerated stretch reflexes. Sustained involuntary muscle activity in the absence of any stretch or any voluntary command contributes to burdensome and disabling body deformities in patients with spastic paresis. Yet, little has been done since Denny-Brown's studies to determine the pathophysiology of this non- stretch or effort related sustained involuntary muscle activity following motor lesions and there is a clear need for research studies in order to improve current therapy. The purpose of the present review is to discuss some of the possible mechanisms that may be involved in the hope that this may guide future research. We discuss the existence of persistent inward currents in spinal motoneurones and present the evidence that the channels involved may be upregulated following central motor lesions. We also discuss a possible contribution from alterations in synaptic inputs from surviving or abnormally branched sensory and descending fibres leading to over-activity and lack of motor coordination. We finally discuss evidence of alterations in motor cortical representational maps and basal ganglia lesions.
Copyright © 2017 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hypertonia; Spastic dystonia; Spasticity

Mesh:

Year:  2017        PMID: 29161622     DOI: 10.1016/j.clinph.2017.10.023

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  12 in total

Review 1.  Spastic movement disorder: should we forget hyperexcitable stretch reflexes and start talking about inappropriate prediction of sensory consequences of movement?

Authors:  Jens Bo Nielsen; Mark Schram Christensen; Simon Francis Farmer; Jakob Lorentzen
Journal:  Exp Brain Res       Date:  2020-05-07       Impact factor: 1.972

2.  Shared and distinct voxel-based lesion-symptom mappings for spasticity and impaired movement in the hemiparetic upper limb.

Authors:  Silvi Frenkel-Toledo; Mindy F Levin; Sigal Berman; Dario G Liebermann; Melanie C Baniña; John M Solomon; Shay Ofir-Geva; Nachum Soroker
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

3.  Left-Right Side-Specific Neuropeptide Mechanism Mediates Contralateral Responses to a Unilateral Brain Injury.

Authors:  Hiroyuki Watanabe; Olga Nosova; Daniil Sarkisyan; Marlene Storm Andersen; Liliana Carvalho; Vladimir Galatenko; Igor Bazov; Nikolay Lukoyanov; Gisela H Maia; Mathias Hallberg; Mengliang Zhang; Jens Schouenborg; Georgy Bakalkin
Journal:  eNeuro       Date:  2021-05-25

4.  Monitoring Involuntary Muscle Activity in Acute Patients with Upper Motor Neuron Lesion by Wearable Sensors: A Feasibility Study.

Authors:  Andrea Merlo; Maria Giulia Montecchi; Francesco Lombardi; Xhejsi Vata; Aurora Musi; Mirco Lusuardi; Roberto Merletti; Isabella Campanini
Journal:  Sensors (Basel)       Date:  2021-04-30       Impact factor: 3.576

5.  Unilateral traumatic brain injury of the left and right hemisphere produces the left hindlimb response in rats.

Authors:  Georgy Bakalkin; Olga Nosova; Daniil Sarkisyan; Mathias Hallberg; Mengliang Zhang; Jens Schouenborg; Niklas Marklund; Hiroyuki Watanabe
Journal:  Exp Brain Res       Date:  2021-05-22       Impact factor: 1.972

6.  Prevalence and Risk Factors for Spasticity After Stroke: A Systematic Review and Meta-Analysis.

Authors:  Huangling Zeng; Jian Chen; Yang Guo; Sheng Tan
Journal:  Front Neurol       Date:  2021-01-20       Impact factor: 4.003

7.  Ipsilesional versus contralesional postural deficits induced by unilateral brain trauma: a side reversal by opioid mechanism.

Authors:  Hiroyuki Watanabe; Olga Nosova; Daniil Sarkisyan; Marlene Storm Andersen; Mengliang Zhang; Linda Rorick-Kehn; Fredrik Clausen; Kinga Gawel; Jan Kehr; Mathias Hallberg; Jens Schouenborg; Niklas Marklund; Georgy Bakalkin
Journal:  Brain Commun       Date:  2020-12-13

8.  Do Muscle Changes Contribute to the Neurological Disorder in Spastic Paresis?

Authors:  Maud Pradines; Mouna Ghédira; Blaise Bignami; Jordan Vielotte; Nicolas Bayle; Christina Marciniak; David Burke; Emilie Hutin; Jean-Michel Gracies
Journal:  Front Neurol       Date:  2022-03-14       Impact factor: 4.003

9.  Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis.

Authors:  Luca Puce; Antonio Currà; Lucio Marinelli; Laura Mori; Elisabetta Capello; Rachele Di Giovanni; Matteo Bodrero; Claudio Solaro; Filippo Cotellessa; Francesco Fattapposta; Carlo Trompetto
Journal:  Clin Neurophysiol Pract       Date:  2021-06-16

10.  Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia.

Authors:  Carlo Trompetto; Lucio Marinelli; Laura Mori; Luca Puce; Chiara Avanti; Elena Saretti; Giulia Biasotti; Roberta Amella; Filippo Cotellessa; Domenico A Restivo; Antonio Currà
Journal:  Toxins (Basel)       Date:  2022-01-05       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.